A new second-line sequential regimen for Helicobacter pylori eradication based on levofloxacin: a pilot study.
Krystallis
C
C
Department of Gastrointestinal Endoscopy, 1st IKA Hospital, End of Zaimi Str, 15127 Melissia, Athens, Greece. Krystallisc@yahoo.com
Kamberoglou
D
D
Pistiolas
D
D
Anifanti
C
C
Koutsoumbas
A
A
Doulgeroglou
V
V
Tzias
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use*; D010865:Pilot Projects; D055815:Young Adult
D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D015242:Ofloxacin
Aliment Pharmacol Ther. 2006 Sep 1;24(5):845-50
16918889
J Clin Gastroenterol. 2006 Jul;40(6):515-20
16825934
Helicobacter. 2009 Dec;14(6):520-4
19889069
Helicobacter. 2009 Apr;14(2):109-18
19298338
Ann Intern Med. 2008 Jun 17;148(12):923-31
18490667
Am J Gastroenterol. 2006 Mar;101(3):488-96
16542284
Am J Gastroenterol. 2008 Jan;103(1):71-6
17764498